11c butanol
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT04050800)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06014515 | Early Phase 1 (Phase 1) | Jan 31, 2024 | National Institutes of Health (NIH), University of California, Davis |
| NCT05876858 | Early Phase 1 (Phase 1) | Jun 13, 2023 | National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH), University of California, Davis |
| NCT04050800 | Early Phase 1 (Phase 1) | Sep 30, 2019 | Cornell University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institutes of Health (NIH) | Government | 2 | 0 | 1 | 2023 |
| University of California, Davis | Academic/Hospital | 2 | 2 | 1 | 2023 |
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| National Center for Complementary and Integrative Health (NCCIH) | Government | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1